THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

PubWeight™: 61.56‹?› | Rank: Top 0.01% | All-Time Top 1000

🔗 View Article (PMC 1202279)

Published in Biochem J on October 01, 1963

Authors

F C GREENWOOD, W M HUNTER, J S GLOVER

Articles citing this

(truncated to the top 100)

The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J (1973) 22.93

An enzymic method for the trace iodination of immunoglobulins and other proteins. Biochem J (1969) 14.06

Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. J Exp Med (1965) 7.27

Nerve growth factor receptors on human melanoma cells in culture. Proc Natl Acad Sci U S A (1977) 6.62

Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A (1978) 6.55

Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A (1980) 6.32

Enzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytes. Biochem J (1971) 5.97

Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. J Cell Biol (1987) 5.79

Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization. J Exp Med (1970) 5.71

Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J Virol (1987) 5.68

Isolation and characterization of the outer membrane of Neisseria gonorrhoeae. J Bacteriol (1974) 5.36

Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med (1973) 5.30

Import of proteins into mitochondria: precursor forms of the extramitochondrially made F1-ATPase subunits in yeast. Proc Natl Acad Sci U S A (1979) 5.21

Ligand-induced movement of lymphocyte membrane macromolecules. I. Analysis by immunofluorescence and ultrastructural radioautography. J Exp Med (1972) 5.01

Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by alveolar macrophages. Proc Natl Acad Sci U S A (1978) 4.95

An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity. J Exp Med (1974) 4.90

O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68

Identification of a major polypeptide of the nuclear pore complex. J Cell Biol (1982) 4.30

Monoclonal antibody characterization of the C proteins of heterogeneous nuclear ribonucleoprotein complexes in vertebrate cells. J Cell Biol (1984) 4.18

IMMUNOGLOBULIN ISOANTIGENS (ALLOTYPES) IN THE MOUSE. I. GENETICS AND CROSS-REACTIONS OF THE 7S GAMMA-2A-ISOANTIGENS CONTROLLED BY ALLELES AT THE IG-1 LOCUS. J Exp Med (1965) 4.07

On the mechanism of membrane damage by Staphylococcus aureus alpha-toxin. J Cell Biol (1981) 4.06

Protein migration into nuclei. I. Frog oocyte nuclei in vivo accumulate microinjected histones, allow entry to small proteins, and exclude large proteins. J Cell Biol (1975) 4.04

Isolation and partial characterization of lymphocyte surface immunoglobulins. J Exp Med (1972) 4.04

Antigens in immunity. 8. Localization of 125-I-labelled antigens in the secondary response. Immunology (1965) 4.00

Antigenic heterogeneity of gonococcal pili. J Exp Med (1975) 3.99

Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol (1984) 3.91

Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84

Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med (1977) 3.80

Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci U S A (1982) 3.75

Studies on the mechanism of solubilization of immune precipitates by serum. J Exp Med (1976) 3.68

Biogenesis of peroxisomes: intracellular site of synthesis of catalase and uricase. Proc Natl Acad Sci U S A (1978) 3.63

Rapid active transport of immunoglobulin A from blood to bile. J Exp Med (1978) 3.62

Biological expressions of lymphocyte activation. II. Generation of a population of thymus-derived suppressor lymphocytes. J Exp Med (1973) 3.50

Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes. Proc Natl Acad Sci U S A (1992) 3.37

Binding of -bungarotoxin to acetylcholine receptors in mammalian muscle (snake venom-denervated muscle-neonatal muscle-rat diaphragm-SDS-polyacrylamide gel electrophoresis). Proc Natl Acad Sci U S A (1972) 3.34

Gonococcal pili. Primary structure and receptor binding domain. J Exp Med (1984) 3.32

A radio-immunoelectrophoretic assay for human growth hormone. Biochem J (1964) 3.29

Quantitative features of a sandwich radioimmunolabeling technique for lymphocyte surface receptors. J Exp Med (1972) 3.28

Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) III. Immunochemical properties of the GAT-specific suppressive factor. J Exp Med (1977) 3.23

A monoclonal antibody against the nuclear pore complex inhibits nucleocytoplasmic transport of protein and RNA in vivo. J Cell Biol (1988) 3.20

Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7. J Virol (1986) 3.17

Variation with age and disease of an amyloid A protein-related serum component. J Clin Invest (1975) 3.17

Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest (1972) 3.13

The localization of antigen in relation to specific antibody-producing cells. I. Use of a synthetic polypeptide [(T,G)-A--L] labelled with iodine-125. Immunology (1966) 3.09

Antigen-specific serotyping of Neisseria gonorrhoeae: characterization based upon principal outer membrane protein. Infect Immun (1981) 3.08

PATHOGENIC FACTORS IN VASULAR LESIONS OF EXPERIMENTAL SERUM SICKNESS. J Exp Med (1965) 3.03

Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J Exp Med (1984) 3.02

Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci U S A (1983) 3.02

Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00

Synthetic peptide with cell attachment activity of fibronectin. Proc Natl Acad Sci U S A (1983) 2.97

Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93

Receptors on immunocompetent cells. II. Specificity and nature of receptors on dinitrophenylated guinea pig albumin- 125 I-binding lymphocytes of normal guinea pigs. J Exp Med (1971) 2.92

Use of anti-idiotypic antibodies as cell-surface receptor probes. Proc Natl Acad Sci U S A (1978) 2.92

Radioimmunoassay of mammalian type-C viral proteins: interspecies antigenic reactivities of the major internal polypeptide. Proc Natl Acad Sci U S A (1972) 2.90

Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia. J Exp Med (1981) 2.89

Immunochemical characterization of a protein associated with Mycobacterium leprae cell wall. Infect Immun (1985) 2.88

Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J Exp Med (1978) 2.85

Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol (1976) 2.82

Isolation of a nucleocapsid polypeptide of herpes simplex virus types 1 and 2 possessing immunologically type-specific and cross-reactive determinants. J Virol (1979) 2.78

Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77

Molecular cloning of integrated simian sarcoma virus: genome organization of infectious DNA clones. Proc Natl Acad Sci U S A (1981) 2.74

Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J Virol (1981) 2.72

Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol (1985) 2.71

Virus-coded origin of a 32,000-dalton protein from avian retrovirus cores: structural relatedness of p32 and the beta polypeptide of the avian retrovirus DNA polymerase. J Virol (1978) 2.70

Staphylococcal enterotoxin B: solid-phase radioimmunoassay. Appl Microbiol (1971) 2.69

Content of elongation factor Tu in Escherichia coli. Proc Natl Acad Sci U S A (1975) 2.68

Identification and characterization of cells deficient in the mannose 6-phosphate receptor: evidence for an alternate pathway for lysosomal enzyme targeting. Proc Natl Acad Sci U S A (1983) 2.67

Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J Exp Med (1993) 2.66

An ultrastructural study of lymphocytes with surface-bound immunoglobulin. J Exp Med (1972) 2.65

Isolation of a laminin-binding protein from muscle cell membranes. EMBO J (1983) 2.57

Primary structure analysis of the major internal protein p24 of human type C T-cell leukemia virus. Proc Natl Acad Sci U S A (1982) 2.57

Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun (1986) 2.56

A precursor protein partly translocated into yeast mitochondria is bound to a 70 kd mitochondrial stress protein. EMBO J (1990) 2.56

Genetic control of immune responses in vitro. II. Cellular requirements for the development of primary plaque-forming cell responses to the random terpolymer 1-glutamic acid 60-1-alanine30-1-tyrosine10 (GAT) by mouse spleen cells in vitro. J Exp Med (1973) 2.56

Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J Exp Med (1984) 2.53

Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med (1972) 2.50

Attachment role of gonococcal pili. Optimum conditions and quantitation of adherence of isolated pili to human cells in vitro. J Clin Invest (1978) 2.50

Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits. Proc Natl Acad Sci U S A (1977) 2.50

Helper-independent mink cell focus-inducing strains of Friend murine type-C virus: potential relationship to the origin of replication-defective spleen focus-forming virus. J Exp Med (1978) 2.48

Isolation and partial molecular characterization of pituitary fibroblast growth factor. Proc Natl Acad Sci U S A (1984) 2.46

Antigen binding and capping by lymphocytes of genetic nonresponder mice. J Exp Med (1972) 2.46

Idiotype expression and the inheritance of mouse antibody clones. J Exp Med (1973) 2.45

Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border. J Cell Biol (1984) 2.42

Recurrent idiotopes and internal images. EMBO J (1982) 2.39

Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol (1984) 2.39

Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5. J Exp Med (1969) 2.38

Monoclonal antibodies to a 28,000 mol. wt protein antigen of Mycobacterium leprae. Clin Exp Immunol (1985) 2.36

Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses. J Virol (1992) 2.36

Binding to collagen by Yersinia enterocolitica and Yersinia pseudotuberculosis: evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol (1989) 2.36

Colony-stimulating factor (CSF) radioimmunoassay: detection of a CSF subclass stimulating macrophage production. Proc Natl Acad Sci U S A (1979) 2.35

CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing. J Virol (2001) 2.34

Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci U S A (1976) 2.34

Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes. Proc Natl Acad Sci U S A (1981) 2.33

The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45. Immunology (1988) 2.32

Characterization of antibody-reactive epitopes on the 65-kilodalton protein of Mycobacterium leprae. Infect Immun (1987) 2.30

Appearance of acetylcholine receptors during differentiation of a myogenic cell line. Proc Natl Acad Sci U S A (1972) 2.29

Antigens in immunity. XIV. Electron microscopic radioautographic studies of antigen capture in the lymph node medulla. J Exp Med (1968) 2.29

Localization of cellular antigens in sodium dodecyl sulfate-polyacrylamide gels. J Cell Biol (1978) 2.29

Idiotype-anti-idiotype regulation. I. Immunization with a levan-binding myeloma protein leads to the appearance of auto-anti-(anti-idiotype) antibodies and to the activation of silent clones. J Exp Med (1981) 2.28

Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J Exp Med (1983) 2.27

Articles by these authors

Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93

Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone. Lancet (1960) 3.36

An evaluation of a chemical method for the estimation of oestriol, oestrone and oestradiol-17 beta in human urine. J Endocrinol (1957) 2.51

An additional purification step for a method for estimating oestriol, oestrone and oestradiol-17 beta in human urine. J Endocrinol (1957) 2.22

Aldosterone secretion and metabolism in normal men and women and in pregnancy. Acta Endocrinol (Copenh) (1959) 1.91

The correlation between urinary oestrogen and vaginal cytology. Lancet (1957) 1.90

STUDIES ON THE SECRETION OF HUMAN-PITUITARY-GROWTH HORMONE. Br Med J (1964) 1.49

Persistence of urinary oestrogen excretion after oophorectomy and adrenalectomy. Br Med J (1957) 1.47

Some enzymic changes in the mammary gland of rats during pregnancy, lactation and mammary involution. Biochem J (1954) 1.42

ASSAY OF HUMAN GROWTH HORMONE IN PREGNANCY AT PARTURITION AND IN LACTATION. DETECTION OF A GROWTH-HORMONE-LIKE SUBSTANCE FROM THE PLACENTA. Br Med J (1964) 1.22

The absent testicle, a report on a survey carried outamong schoolboys in Nottingham. Br Med J (1960) 1.22

The spectrophotometric measurement of enzymically produced oxaloacetic acid. Biochim Biophys Acta (1953) 1.14

GROWTH-HORMONE LEVELS IN CHILDREN AND ADOLESCENTS. Br Med J (1964) 1.02

Adrenalectomy in breast cancer; an attempt to correlate clinical results with oestrogen production. Br Med J (1958) 0.97

Oophorectomy in breast cancer; an attempt to correlate clinical results with oestrogen production. Br Med J (1958) 0.94

Glutamic dehydrogenase and glutamic-aspartic transaminase in regenerating liver of the rat. J Physiol (1954) 0.90

Hormone excretion in prostatic cancer: the early and late effects of endocrine treatment on urinary oestrogens, 17-ketosteroids and 17-ketogenic steroids. Acta Endocrinol (Copenh) (1959) 0.83

A 34-YEAR CLINICAL STUDY OF UTERINE SARCOMA INCLUDING EXPERIENCE WITH CHEMOTHERAPY. Obstet Gynecol (1965) 0.80

Effect of hypophysectomy on urinary oestrogen in breast cancer. Br Med J (1957) 0.79

Comparison of biological and chemical estimations of urinary oestrogens. I. Urine from normal men and women and a eunuch. J Endocrinol (1957) 0.79

Hormone excretion in precocious puberty in girls. Arch Dis Child (1958) 0.78

THE STATE OF IATROGENIC (STEROID-INDUCED) PSEUDOPREGNANCY AND ITS SEQUELAE. Gaz Med Port (1965) 0.78

Hormone excretion in prostatic cancer: an attempt to correlate urinary hormone excretion and clinical state. Br J Cancer (1959) 0.77

Hypophysectomy in breast cancer; an attempt to correlate clinical results with oestrogen production. Br Med J (1958) 0.76

Poultry diseases. Can J Comp Med Vet Sci (1948) 0.75

Effect of intramuscular injections of heparin on the blood clotting time and bleeding time of chickens. Can J Comp Med Vet Sci (1950) 0.75

Enterohepatitis in turkeys; interim report on result of treatments used. Can J Comp Med Vet Sci (1948) 0.75

The isolation of androsterone and aeticholanolone from the urine of oophorectomised-adrenalectomised women. Biochim Biophys Acta (1960) 0.75

GROWTH-HORMONE SECRETION IN TREATED AND UNTREATED ACROMEGALY. UCRL-11833. UCRL US At Energy Comm (1964) 0.75

Report of treatment of infectious sinusitis in turkeys with streptomycin. Can J Comp Med Vet Sci (1950) 0.75

Comparison of biological and chemical estimations of urinary oestrogens. II. Urine from patients with breast cancer maintained on cortisone after oophorectomy-adrenalectomy or hypophysectomy. J Endocrinol (1960) 0.75

Changes in oestrogen titre in stored urine. Nature (1959) 0.75

The persistence of oestrogen production after endocrine ablation. Acta Endocrinol Suppl (Copenh) (1957) 0.75